Merck & Co. - Biosimilars Business' Unit Acquisition

Merck & Co. - Biosimilars Business raised a round of funding on April 25, 2017. Investors include Fresenius Medical Care.

Merck & Co. (NYSE: MRK) is a global healthcare company. Through its prescription medicines, vaccines, biologic therapies, and animal health products, the company works with customers and operates in m…

Articles about Merck & Co. - Biosimilars Business' Unit Acquisition: